Incannex Healthcare Statistics
Total Valuation
IXHL has a market cap or net worth of $158.09 million. The enterprise value is $85.02 million.
Important Dates
The last earnings date was Friday, November 14, 2025, before market open.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IXHL has 346.23 million shares outstanding. The number of shares has increased by 548.06% in one year.
| Current Share Class | 346.23M |
| Shares Outstanding | 346.23M |
| Shares Change (YoY) | +548.06% |
| Shares Change (QoQ) | +273.41% |
| Owned by Insiders (%) | 12.52% |
| Owned by Institutions (%) | 2.81% |
| Float | 302.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13,173.88 |
| Forward PS | 166.43 |
| PB Ratio | 2.06 |
| P/TBV Ratio | 2.05 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7,084.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 47.51, with a Debt / Equity ratio of 0.00.
| Current Ratio | 47.51 |
| Quick Ratio | 47.35 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -75.89 |
Financial Efficiency
Return on equity (ROE) is -114.52% and return on invested capital (ROIC) is -34.13%.
| Return on Equity (ROE) | -114.52% |
| Return on Assets (ROA) | -30.33% |
| Return on Invested Capital (ROIC) | -34.13% |
| Return on Capital Employed (ROCE) | -29.84% |
| Revenue Per Employee | $1,000 |
| Profits Per Employee | -$3.99M |
| Employee Count | 12 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -73.52% in the last 52 weeks. The beta is 2.60, so IXHL's price volatility has been higher than the market average.
| Beta (5Y) | 2.60 |
| 52-Week Price Change | -73.52% |
| 50-Day Moving Average | 0.39 |
| 200-Day Moving Average | 0.50 |
| Relative Strength Index (RSI) | 63.87 |
| Average Volume (20 Days) | 23,616,829 |
Short Selling Information
The latest short interest is 22.27 million, so 6.43% of the outstanding shares have been sold short.
| Short Interest | 22.27M |
| Short Previous Month | 29.32M |
| Short % of Shares Out | 6.43% |
| Short % of Float | 7.37% |
| Short Ratio (days to cover) | 1.03 |
Income Statement
In the last 12 months, IXHL had revenue of $12,000 and -$47.87 million in losses. Loss per share was -$0.44.
| Revenue | 12,000 |
| Gross Profit | 12,000 |
| Operating Income | -23.00M |
| Pretax Income | -47.87M |
| Net Income | -47.87M |
| EBITDA | -22.85M |
| EBIT | -23.00M |
| Loss Per Share | -$0.44 |
Full Income Statement Balance Sheet
The company has $73.28 million in cash and $210,000 in debt, giving a net cash position of $73.07 million or $0.21 per share.
| Cash & Cash Equivalents | 73.28M |
| Total Debt | 210,000 |
| Net Cash | 73.07M |
| Net Cash Per Share | $0.21 |
| Equity (Book Value) | 77.01M |
| Book Value Per Share | 0.22 |
| Working Capital | 76.65M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$19.43 million and capital expenditures -$10,000, giving a free cash flow of -$19.44 million.
| Operating Cash Flow | -19.43M |
| Capital Expenditures | -10,000 |
| Free Cash Flow | -19.44M |
| FCF Per Share | -$0.06 |
Full Cash Flow Statement Margins
| Gross Margin | 100.00% |
| Operating Margin | -191,625.00% |
| Pretax Margin | -398,933.33% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |